More effective immunosuppression with the use of FK506 after liver transplantation.
Lo
C M
CM
Liver Disease Center, University of Hong Kong Medical Center, Queen Mary Hospital, Hong Kong, China.
Fan
S T
ST
Liu
C L
CL
Ng
I O
IO
Lam
B K
BK
Yong
B H
BH
Lai
C L
CL
Lau
G K
GK
Wong
J
J
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000453:epidemiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology*; D008875:Middle Aged; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus